Inca Worldwide (OTC-Pink:QEDN) Completes Testing on Chickens
Inca Worldwide Inc. announces it has completed its first test of it protein on chickens. The first results of the test was on farming chickens and it was found to increase production of eggs 33%. The company will be testing the individual eggs to determine the increase in Omega 3,6,and 9. Kate Bahnsen states:” Having a proprietary facility and processing our product in Turbo Antioquia will help to reduce cost and turn around our product in 1 days instead of 45 days. We have reduced our cost, and the Sacha Inchi that doesn’t meet the standard for human consumption we can utilize for animal consumption. We intend to utilize the entire shell, and the seed, leaving us with very little waste. We have found Sacha Inchi to be one of the most versatile foods products ever to be sold.”
Contact information: firstname.lastname@example.org
About Inca Worldwide
Our Inca Seeds (Roasted Sacha Inchi) a complete protein with all 9-essential amino-acids rich in Omega 3, 6 & 9 and an antioxidant. A real Super-food.
Caution Concerning Forward-Looking Statements:
Our public communications and SEC filings may contain "forward-looking statements" – that is, statements related to future, not past, events. In this context, forward-looking statements often address our expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," or "target."
Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about our announced plan to reduce the size of our financial services businesses, including expected cash and non-cash charges associated with this plan and earnings per share of QED retained businesses (Verticals); expected income; earnings per share; revenues; organic growth; growth and productivity associated with our Digital business; margins; cost structure; restructuring charges; acquisition-related synergies; cash flows; returns on capital and investment; capital expenditures, capital allocation or capital structure; and dividends.